Opioid-induced gut microbial disruption and bile dysregulation leads to gut barrier compromise and sustained systemic inflammation

Pathogen Recognition and Innate Immunity

Akira, S., Uematsu, S., & Takeuchi, O. (2006) · Cell · doi:10.1016/j.cell.2006.02.015 · Cited by 11,974 · see citing works

Intestinal mucosal barrier function in health and disease

Turner, J. R. (2009) · Nature reviews. Immunology · doi:10.1038/nri2653 · Cited by 3,952 · see citing works

The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age

Mariat, D., Firmesse, O., Levenez, F., Guimarăes, V., Sokol, H., Doré, J., Corthier, G., & Furet, J.-P. (2009) · BMC Microbiology · doi:10.1186/1471-2180-9-123 · Cited by 1,755 · see citing works

Bile acids and the gut microbiome

Ridlon, J. M., Kang, D. J., Hylemon, P. B., & Bajaj, J. S. (2014) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000057 · Cited by 1,329 · see citing works

Functional and comparative metagenomic analysis of bile salt hydrolase activity in the human gut microbiome

Jones, B. V., Begley, M., Hill, C., Gahan, C. G. M., & Marchesi, J. R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804437105 · Cited by 1,098 · see citing works

Commensal bacteria at the interface of host metabolism and the immune system

Brestoff, J. R., & Artis, D. (2013) · Nature Immunology · doi:10.1038/ni.2640 · Cited by 945 · see citing works

Bile acid signaling in metabolic disease and drug therapy

Li, T., & Chiang, J. Y. L. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.008201 · Cited by 935 · see citing works

Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection

Hamilton, M. J., Weingarden, A. R., Sadowsky, M. J., & Khoruts, A. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2011.482 · Cited by 738 · see citing works

Changes in the Composition of the Human Fecal Microbiome After Bacteriotherapy for Recurrent Clostridium difficile-associated Diarrhea

Khoruts, A., Dicksved, J., Jansson, J. K., & Sadowsky, M. J. (2010) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3181c87e02 · Cited by 649 · see citing works

Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients

Kelly, C. R., Ihunnah, C., Fischer, M., Khoruts, A., Surawicz, C., Afzali, A., Aroniadis, O., Barto, A., Borody, T., Giovanelli, A., et al. (2014) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.133 · Cited by 636 · see citing works

Intestinal transport and metabolism of bile acids

Dawson, P. A., & Karpen, S. J. (2015) · Journal of Lipid Research · doi:10.1194/jlr.r054114 · Cited by 598 · see citing works

A simple model host for identifying Gram-positive virulence factors

Garsin, D. A., Sifri, C. D., Mylonakis, E. E., Qin, X., Singh, K. V., Murray, B. E., Calderwood, S. B., & Ausubel, F. M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191378698 · Cited by 570 · see citing works

Probiotics, Prebiotics and Immunomodulation of Gut Mucosal Defences: Homeostasis and Immunopathology

Hardy, H., Harris, J., Lyon, E., Beal, J., & Foey, A. (2013) · Nutrients · doi:10.3390/nu5061869 · Cited by 551 · see citing works

Microbial Translocation Across the GI Tract

Brenchley, J. M., & Douek, D. C. (2012) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-075001 · Cited by 496 · see citing works

Intestinal microbiota, diet and health

Power, S. E., O'Toole, P. W., Stanton, C., Ross, R. P., & Fitzgerald, G. F. (2014) · British Journal Of Nutrition · doi:10.1017/s0007114513002560 · Cited by 476 · see citing works

Microbiota transplantation restores normal fecal bile acid composition in recurrent<i>Clostridium difficile</i>infection

Weingarden, A. R., Chen, C., Bobr, A., Yao, D., Lu, Y., Nelson, V. M., Sadowsky, M. J., & Khoruts, A. (2014) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00282.2013 · Cited by 423 · see citing works

Role of the gut microbiota in defining human health

Fujimura, K. E., Slusher, N. A., Cabana, M. D., & Lynch, S. V. (2010) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.10.14 · Cited by 408 · see citing works

Opioid Drug Abuse and Modulation of Immune Function: Consequences in the Susceptibility to Opportunistic Infections

Roy, S., Ninković, J., Banerjee, S., Charboneau, R., Das, S., Dutta, R., Kirchner, V. A., Koodie, L., Ma, J., Meng, J., et al. (2011) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-011-9292-5 · Cited by 309 · see citing works

THE BIOLOGICAL CONVERSION OF CHOLESTEROL TO CHOLIC ACID

Bloch, K., Berg, B. N., & Rittenberg, D. (1943) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)72197-2 · Cited by 231 · see citing works

A novel mechanism for gut barrier dysfunction by dietary fat: epithelial disruption by hydrophobic bile acids

Stenman, L. K., Holma, R., Eggert, A., & Korpela, R. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00267.2012 · Cited by 222 · see citing works

Morphine induces bacterial translocation in mice by compromising intestinal barrier function in a TLR-dependent manner

Meng, J., Yu, H., Ma, J., Wang, J., Banerjee, S., Charboneau, R., Barke, R. A., & Roy, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054040 · Cited by 212 · see citing works

High-fat-induced intestinal permeability dysfunction associated with altered fecal bile acids

Stenman, L. K. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i9.923 · Cited by 201 · see citing works

Morphine Impairs Host Innate Immune Response and Increases Susceptibility to Streptococcus pneumoniae Lung Infection

Wang, J., Barke, R. A., Charboneau, R., & Roy, S. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.1.426 · Cited by 184 · see citing works

IL-17 produced by Paneth cells drives TNF-induced shock

Takahashi, N., Vanlaere, I., Rycke, R. M. D., Cauwels, A., Joosten, L. A. B., Lubberts, E., van den Berg, W. B., & Libert, C. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080588 · Cited by 182 · see citing works

Colonic inflammation and secondary bile acids in alcoholic cirrhosis

Kakiyama, G., Hylemon, P. B., Zhou, H., Pandak, W. M., Heuman, D. M., Kang, D. J., Takei, H., Nittono, H., Ridlon, J. M., Fuchs, M. A., et al. (2014) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00315.2013 · Cited by 180 · see citing works

The dual nature of TH17 cells: shifting the focus to function

O'Connor, W., Zenewicz, L. A., & Flavell, R. A. (2010) · Nature Immunology · doi:10.1038/ni.1882 · Cited by 178 · see citing works

Hypocholesterolaemic effect of dietary inclusion of two putative probiotic bile salt hydrolase-producing Lactobacillus plantarum strains in Sprague–Dawley rats

Kumar, R., Grover, S., & Batish, V. K. (2010) · British Journal Of Nutrition · doi:10.1017/s0007114510003740 · Cited by 158 · see citing works

Morphine Induces Sepsis in Mice

Hilburger, M. E., Adler, M. W., Truant, A. L., Meissler, J. J., Satishchandran, V., Rogers, T. J., & Eisenstein, T. K. (1997) · The Journal of Infectious Diseases · doi:10.1086/514021 · Cited by 155 · see citing works

Regulation of epithelial immunity by IL-17 family cytokines

Pappu, R., Rutz, S., & Ouyang, W. (2012) · Trends in Immunology · doi:10.1016/j.it.2012.02.008 · Cited by 129 · see citing works

Pseudomonas aeruginosa virulence expression is directly activated by morphine and is capable of causing lethal gut-derived sepsis in mice during chronic morphine administration

Babrowski, T., Holbrook, C., Moss, J., Gottlieb, L., Valuckaite, V., Zaborin, A., Poroyko, V., Liu, D. C., Zaborina, O., & Alverdy, J. C. (2012) · Annals of Surgery · doi:10.1097/sla.0b013e3182331870 · Cited by 129 · see citing works

Gut Microbiota Dysbiosis Is Associated with Inflammation and Bacterial Translocation in Mice with CCl4-Induced Fibrosis

Gómez‐Hurtado, I., Santacruz, A., Peiró, G., Zapater, P., Gutiérrez, A., Pérez‐Mateo, M., Sanz, Y., & Francés, R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023037 · Cited by 128 · see citing works

Gut microbiota, epithelial function and derangements in obesity

Raybould, H. E. (2011) · The Journal of Physiology · doi:10.1113/jphysiol.2011.222133 · Cited by 110 · see citing works

Opioid Exacerbation of Gram-positive sepsis, induced by Gut Microbial Modulation, is Rescued by IL-17A Neutralization

Meng, J., Banerjee, S., Li, D., Sindberg, G. M., Wang, F., Ma, J., & Roy, S. (2015) · Scientific Reports · doi:10.1038/srep10918 · Cited by 109 · see citing works

The Bile Acid Sensor FXR Is Required for Immune-Regulatory Activities of TLR-9 in Intestinal Inflammation

Renga, B., Mencarelli, A., Cipriani, S., D’Amore, C., Carino, A., Bruno, A. M., Francisci, D., Zampella, A., Distrutti, E., & Fiorucci, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054472 · Cited by 106 · see citing works

Therapeutic transplantation of the distal gut microbiota

Khoruts, A., & Sadowsky, M. J. (2010) · Mucosal Immunology · doi:10.1038/mi.2010.79 · Cited by 86 · see citing works

Chronic morphine accelerates the progression of lipopolysaccharide-induced sepsis to septic shock

Ocasio, F., Jiang, Y., House, S. D., & Chang, S. L. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2003.12.016 · Cited by 86 · see citing works

Role of farnesoid X receptor in inflammation and resolution

Shaik, F. B., Prasad, D. V. R., & Narala, V. R. (2014) · Inflammation Research · doi:10.1007/s00011-014-0780-y · Cited by 67 · see citing works

The gut microbiome, probiotics, bile acids axis, and human health

Jones, M. L., Tomaro-Duchesneau, C., & Prakash, S. (2014) · Trends in Microbiology · doi:10.1016/j.tim.2014.04.010 · Cited by 64 · see citing works

Morphine induced exacerbation of sepsis is mediated by tempering endotoxin tolerance through modulation of miR-146a

Banerjee, S., Meng, J., Das, S., Krishnan, A., Haworth, J., Charboneau, R., Zeng, Y., Ramakrishnan, S., & Roy, S. (2013) · Scientific Reports · doi:10.1038/srep01977 · Cited by 63 · see citing works

Morphine Decreases Bacterial Phagocytosis by Inhibiting Actin Polymerization through cAMP-, Rac-1-, and p38 MAPK-Dependent Mechanisms

Ninković, J., & Roy, S. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.11.034 · Cited by 60 · see citing works

Immune and genetic gardening of the intestinal microbiome

Jacobs, J. P., & Braun, J. G. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.02.052 · Cited by 56 · see citing works

Development of Fecal Microbiota Transplantation Suitable for Mainstream Medicine

Khoruts, A., Sadowsky, M. J., & Hamilton, M. J. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.11.014 · Cited by 55 · see citing works

Morphine Modulation of Toll-Like Receptors in Microglial Cells Potentiates Neuropathogenesis in a HIV-1 Model of Coinfection with Pneumococcal Pneumoniae

Dutta, R. K., Krishnan, A., Meng, J., Das, S. R., Ma, J., Banerjee, S., Wang, J., Charboneau, R., Prakash, O., Barke, R. A., et al. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.0870-12.2012 · Cited by 42 · see citing works

Antigenicity and Immunogenicity of Plasmodium vivax Merozoite Surface Protein-3

Bitencourt, A. R., Vicentin, E. C. M., Jiménez, M. C. H., Ricci, R., Leite, J. A., Costa, F. T. M., Ferreira, L. C. D. S., Russell, B., Nosten, F. H., Rénia, L., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056061 · Cited by 41 · see citing works

HIV-1 Coinfection and Morphine Coexposure Severely Dysregulate Hepatitis C Virus-Induced Hepatic Proinflammatory Cytokine Release and Free Radical Production: Increased Pathogenesis Coincides with Uncoordinated Host Defenses

El‐Hage, N., Dever, S. M., Fitting, S., Ahmed, T., & Hauser, K. F. (2011) · Journal of Virology · doi:10.1128/jvi.05239-11 · Cited by 40 · see citing works

Shuttling of information between the mucosal and luminal environment drives intestinal homeostasis

Asselin, C., & Gendron, F. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.02.049 · Cited by 37 · see citing works

An Infectious Murine Model for Studying the Systemic Effects of Opioids on Early HIV Pathogenesis in the Gut

Sindberg, G. M., Sharma, U., Banerjee, S., Anand, V., Dutta, R., Gu, C., Volsky, D. J., & Roy, S. (2014) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-014-9574-9 · Cited by 34 · see citing works

Microbiome: The bacterial tightrope

Bourzac, K. (2014) · Nature · doi:10.1038/516s14a · Cited by 28 · see citing works

Probiotics in gnotobiotic miceConversion of cholesterol to coprostanol in vitro and in vivo and bile acid deconjugation in vitro

Cardona, M. E., Vanay, V. D. V., Midtvedt, T., & Norin, K. E. (2000) · Microbial Ecology in Health and Disease · doi:10.1080/08910600050216200 · Cited by 22 · see citing works

TLR2 Activation Enhances HIV Nuclear Import and Infection through T Cell Activation-Independent and -Dependent Pathways

Ding, J., & Chang, T. L.-Y. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1102098 · Cited by 18 · see citing works

Potentiating effect of morphine on oral Salmonella enterica serovar Typhimurium infection is μ-opioid receptor-dependent

Deckman, J. M., Feng, P., Meissler, J. J., Pintar, J. E., Gaughan, J., Adler, M. W., & Eisenstein, T. K. (2010) · Microbial Pathogenesis · doi:10.1016/j.micpath.2010.07.006 · Cited by 12 · see citing works

Morphine exacerbates experimental sepsis by modulating IL17/IL22 response (IRC8P.488)

Meng, J., Li, D., Roy, S., & Wang, F. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.192.supp.190.16 · Cited by 1 · see citing works

Opioids and the immune system – friend or foe

Plein, L. M., & Rittner, H. L. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13750 · Cited by 483 · see citing works

Immunological mechanisms of inflammatory diseases caused by gut microbiota dysbiosis: A review

Zhao, M., Chu, J., Feng, S., Guo, C., Xue, B., He, K., & Li, L. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114985 · Cited by 466 · see citing works

Pain regulation by gut microbiota: molecular mechanisms and therapeutic potential

Guo, R., Chen, L., Xing, C., & Liu, T. (2019) · British Journal of Anaesthesia · doi:10.1016/j.bja.2019.07.026 · Cited by 416 · see citing works

Integrated analysis of concomitant medications and oncological outcomes from PD-1/PD-L1 checkpoint inhibitors in clinical practice

Cortellini, A., Tucci, M., Adamo, V., Stucci, L. S., Russo, A., Tanda, E. T., Spagnolo, F., Rastelli, F., Bisonni, R., Santini, D., et al. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-001361 · Cited by 275 · see citing works

Gut-Brain Psychology: Rethinking Psychology From the Microbiota–Gut–Brain Axis

Liang, S., Wu, X., & Jin, F. (2018) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2018.00033 · Cited by 269 · see citing works

Systematic review: human gut dysbiosis induced by non-antibiotic prescription medications

Le Bastard, Q., Al‐Ghalith, G. A., Grégoire, M., Chapelet, G., Javaudin, F., Dailly, E., Batard, E., Knights, D., & Montassier, E. (2018) · Alimentary Pharmacology &amp; Therapeutics · doi:10.1111/apt.14451 · Cited by 263 · see citing works

Morphine induces changes in the gut microbiome and metabolome in a morphine dependence model

Wang, F., Meng, J., Zhang, L., Johnson, T., Chen, C., & Roy, S. (2018) · Scientific Reports · doi:10.1038/s41598-018-21915-8 · Cited by 238 · see citing works

Gut microbiota and osteoarthritis management: An expert consensus of the European society for clinical and economic aspects of osteoporosis, osteoarthritis and musculoskeletal diseases (ESCEO)

Biver, E., Berenbaum, F., Valdes, A. M., de Carvalho, I. A., Bindels, L. B., Brandi, M. L., Calder, P. C., Castronovo, V., Cavalier, E., Cherubini, A., et al. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.100946 · Cited by 185 · see citing works

Chronic opioid use is associated with altered gut microbiota and predicts readmissions in patients with cirrhosis

Acharya, C., Betrapally, N. S., Gillevet, P. M., Sterling, R. K., Akbarali, H., White, M. B., Ganapathy, D., Fagan, A., Sikaroodi, M., & Bajaj, J. S. (2017) · Alimentary Pharmacology &amp; Therapeutics · doi:10.1111/apt.13858 · Cited by 175 · see citing works

The gut microbiota mediates reward and sensory responses associated with regimen-selective morphine dependence

Lee, K., Vuong, H. E., Nusbaum, D. J., Hsiao, E. Y., Evans, C. J., & Taylor, A. M. W. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0211-9 · Cited by 172 · see citing works

The effects of dairy and dairy derivatives on the gut microbiota: a systematic literature review

Aslam, H., Marx, W., Rocks, T., Loughman, A., Chandrasekaran, V., Ruusunen, A., Dawson, S. L., West, M., Mullarkey, E., Pasco, J. A., et al. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1799533 · Cited by 170 · see citing works

Microbiota-Immune Interaction in the Pathogenesis of Gut-Derived Infection

Wang, C., Li, Q., & Ren, J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01873 · Cited by 167 · see citing works

Morphine tolerance is attenuated in germfree mice and reversed by probiotics, implicating the role of gut microbiome

Zhang, L., Meng, J., Ban, Y. J., Jalodia, R., Chupikova, I., Fernández, I., Brito, N., Sharma, U., Abreu, M. T., Ramakrishnan, S., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1901182116 · Cited by 160 · see citing works

A potential role for the gut microbiome in substance use disorders

Meckel, K. R., & Kiraly, D. D. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05232-0 · Cited by 141 · see citing works

Gut microbiota regulates neuropathic pain: potential mechanisms and therapeutic strategy

Lin, B., Wang, Y., Zhang, P., Yuan, Y., Zhang, Y., & Chen, G. (2020) · The Journal of Headache and Pain · doi:10.1186/s10194-020-01170-x · Cited by 131 · see citing works

Gut Homeostasis, Microbial Dysbiosis, and Opioids

Wang, F., & Roy, S. (2016) · Toxicologic Pathology · doi:10.1177/0192623316679898 · Cited by 128 · see citing works

Microbial dysbiosis and polyamine metabolism as predictive markers for early detection of pancreatic cancer

Méndez, R., Kesh, K., Arora, N., Martino, L. D., McAllister, F. M., Merchant, N. B., Banerjee, S., & Banerjee, S. (2019) · Carcinogenesis · doi:10.1093/carcin/bgz116 · Cited by 125 · see citing works

Food pyramid for subjects with chronic pain: foods and dietary constituents as anti-inflammatory and antioxidant agents

Rondanelli, M., Faliva, M. A., Miccono, A., Naso, M., Nichetti, M., Riva, A., Guerriero, F., Gregori, M. D., Peroni, G., & Perna, S. (2018) · Nutrition Research Reviews · doi:10.1017/s0954422417000270 · Cited by 124 · see citing works

Lactobacillus plantarum DR7 improved upper respiratory tract infections via enhancing immune and inflammatory parameters: A randomized, double-blind, placebo-controlled study

Chong, H.-X., Yusoff, N. A. A., Hor, Y.-Y., Lew, L.-C., Jaafar, M. H., Choi, S. B., Yusoff, M. S. B., Wahid, N. A., Abdullah, M. F. I. L. B., Zakaria, N., et al. (2019) · Journal of Dairy Science · doi:10.3168/jds.2018-16103 · Cited by 121 · see citing works

The gut microbiome and the mechanism of surgical infection

Alverdy, J. C., Hyoju, S. K., Weigerinck, M., & Gilbert, J. A. (2017) · British journal of surgery · doi:10.1002/bjs.10405 · Cited by 119 · see citing works

Gut microbiota varies by opioid use, circulating leptin and oxytocin in African American men with diabetes and high burden of chronic disease

Barengolts, E., Green, S. J., Eisenberg, Y., Akbar, A., Reddivari, B., Layden, B. T., Dugas, L., & Chlipala, G. (2018) · PLoS ONE · doi:10.1371/journal.pone.0194171 · Cited by 111 · see citing works

Neuroimmune mechanisms of psychostimulant and opioid use disorders

Hofford, R. S., Russo, S. J., & Kiraly, D. D. (2018) · European Journal of Neuroscience · doi:10.1111/ejn.14143 · Cited by 92 · see citing works

The Role of Bacteria and Its Derived Metabolites in Chronic Pain and Depression: Recent Findings and Research Progress

Li, S., Hua, D., Wang, Q., Yang, L., Wang, X., Luo, A., & Yang, C. (2019) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyz061 · Cited by 91 · see citing works

Interactions between NSAIDs, opioids and the gut microbiota - Future perspectives in the management of inflammation and pain

Zádori, Z., Király, K. P., Al‐Khrasani, M., & Gyires, K. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108327 · Cited by 90 · see citing works

Gut microbial dysbiosis in individuals with Sjögren’s syndrome

Méndez, R., Watane, A., Farhangi, M., Cavuoto, K. M., Leith, T., Budree, S., Galor, A., & Banerjee, S. (2020) · Microbial Cell Factories · doi:10.1186/s12934-020-01348-7 · Cited by 90 · see citing works

The ameliorative effect of Lactobacillus plantarum Y44 oral administration on inflammation and lipid metabolism in obese mice fed with a high fat diet

Liu, Y., Gao, Y., Ma, F., Sun, M., Mu, G., & Tuo, Y. (2020) · Food & Function · doi:10.1039/d0fo00439a · Cited by 90 · see citing works

Gut microbiome, surgical complications and probiotics

Stavrou, G. (2016) · Annals of Gastroenterology · doi:10.20524/aog.2016.0086 · Cited by 84 · see citing works

Concomitant medications and immune checkpoint inhibitor therapy for cancer: causation or association?

Hussain, N., Naeem, M., & Pinato, D. J. (2021) · Human Vaccines &amp; Immunotherapeutics · doi:10.1080/21645515.2020.1769398 · Cited by 69 · see citing works

Gut Microbiome in Anesthesiology and Pain Medicine

Minerbi, A., & Shen, S. (2022) · Anesthesiology · doi:10.1097/aln.0000000000004204 · Cited by 73 · see citing works

The role of the gut microbiome in opioid use

Ren, M., & Lotfipour, S. (2019) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000538 · Cited by 68 · see citing works

Alterations in microbiome composition and metabolic byproducts drive behavioral and transcriptional responses to morphine

Hofford, R. S., Mervosh, N. L., Euston, T. J., Meckel, K. R., Orr, A. T., & Kiraly, D. D. (2021) · Neuropsychopharmacology · doi:10.1038/s41386-021-01043-0 · Cited by 64 · see citing works

“Under the Skin” and into the Gut: Social Epidemiology of the Microbiome

Dowd, J. B., & Renson, A. (2018) · Current Epidemiology Reports · doi:10.1007/s40471-018-0167-7 · Cited by 65 · see citing works

Opioids Impair Intestinal Epithelial Repair in HIV-Infected Humanized Mice

Meng, J., Banerjee, S., Zhang, L., Sindberg, G. M., Moidunny, S., Li, B., Robbins, D. J., Girotra, M., Segura, B. J., Ramakrishnan, S., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02999 · Cited by 65 · see citing works

Opioid agonist and antagonist use and the gut microbiota: associations among people in addiction treatment

Gicquelais, R. E., Bohnert, A. M., Thomas, L., & Foxman, B. (2020) · Scientific Reports · doi:10.1038/s41598-020-76570-9 · Cited by 64 · see citing works

All disease begins in the gut: Influence of gastrointestinal disorders and surgery on oral drug performance

Hatton, G. B., Madla, C. M., Rabbie, S. C., & Basit, A. W. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.06.054 · Cited by 64 · see citing works

Opioid system influences gut-brain axis: Dysbiosis and related alterations

Rueda‐Ruzafa, L., Cruz, F., Cardona, D., Hone, A. J., Molina‐Torres, G., Sánchez‐Labraca, N., & Román, P. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104928 · Cited by 64 · see citing works

Gastrointestinal biotransformation of phytochemicals: Towards futuristic dietary therapeutics and functional foods

Singh, B., Mal, G., Sharma, D., Sharma, R., Antony, C. P., & Kalra, R. S. (2020) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2020.09.022 · Cited by 64 · see citing works

Prescription opioids are associated with higher mortality in patients diagnosed with sepsis: A retrospective cohort study using electronic health records

Zhang, R., Meng, J., Lian, Q., Chen, X., Bauman, B. D., Chu, H., Segura, B. J., & Roy, S. (2018) · PLoS ONE · doi:10.1371/journal.pone.0190362 · Cited by 62 · see citing works

Prescription Opioids induce Gut Dysbiosis and Exacerbate Colitis in a Murine Model of Inflammatory Bowel Disease

Sharma, U., Olson, R., Erhart, F. N., Zhang, L., Meng, J., Segura, B. J., Banerjee, S., Sharma, M., Saluja, A. K., Ramakrishnan, S., et al. (2019) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjz188 · Cited by 60 · see citing works

Drugs and Bugs: The Gut-Brain Axis and Substance Use Disorders

Simpson, S., Mclellan, R., Wellmeyer, E., Matalon, F., & George, O. (2021) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-021-10022-7 · Cited by 61 · see citing works

Multi-omics analysis revealing the interplay between gut microbiome and the host following opioid use

Kolli, U., Jalodia, R., Moidunny, S., Singh, P. K., Ban, Y. J., Tao, J., Cantu, G. N., Valdes, E., Ramakrishnan, S., & Roy, S. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2246184 · Cited by 59 · see citing works

The effect of opioids on gastrointestinal function in the ICU

Yan, Y., Chen, Y., & Zhang, X. (2021) · Critical Care · doi:10.1186/s13054-021-03793-1 · Cited by 55 · see citing works

Less Well-Known Consequences of the Long-Term Use of Opioid Analgesics: A Comprehensive Literature Review

KotliÅ„ska-Lemieszek, A., & Zylicz, Z. (2022) · Drug Design Development and Therapy · doi:10.2147/dddt.s342409 · Cited by 56 · see citing works

Effects of Substance Use and Sex Practices on the Intestinal Microbiome During HIV-1 Infection

Fulcher, J. A., Hussain, S. K., Cook, R., Li, F., Tobin, N. H., Ragsdale, A. M., SHOPTAW, S. J., Gorbach, P. M., & Aldrovandi, G. M. (2018) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiy349 · Cited by 55 · see citing works

Alterations to the Gastrointestinal Microbiome Associated with Methamphetamine Use among Young Men who have Sex with Men

Cook, R., Fulcher, J. A., Tobin, N. H., Li, F., Lee, D., Woodward, C. L., Javanbakht, M., Brookmeyer, R., SHOPTAW, S. J., Bolan, R., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-51142-8 · Cited by 55 · see citing works

Opioids and Chronic Pain: Where Is the Balance?

Davis, M. P., & Mehta, Z. Y. (2016) · Current Oncology Reports · doi:10.1007/s11912-016-0558-1 · Cited by 51 · see citing works

Effect of clinical parameters on the ocular surface microbiome in children and adults

Cavuoto, K. M., Méndez, R., Miller, D., Galor, A., & Banerjee, S. (2018) · Clinical ophthalmology · doi:10.2147/opth.s166547 · Cited by 51 · see citing works

Rethinking the bile acid/gut microbiome axis in cancer

Phelan, J. P., Reen, F. J., Caparros-Martin, J. A., O’Connor, R., & O’Gara, F. (2017) · Oncotarget · doi:10.18632/oncotarget.22803 · Cited by 50 · see citing works

Spexin Acts as Novel Regulator for Bile Acid Synthesis

Lin, C., Zhao, L., Huang, T., Lü, L., Khan, M., Liu, J., Zhong, L. L. D., Cai, Z., Fan, B., Wong, A., et al. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00378 · Cited by 52 · see citing works

Fecal microbiota transplantation and antibiotic treatment attenuate naloxone-precipitated opioid withdrawal in morphine-dependent mice

Thomaz, A. C., Iyer, V., Woodward, T. J., & Hohmann, A. G. (2021) · Experimental Neurology · doi:10.1016/j.expneurol.2021.113787 · Cited by 46 · see citing works

The role of opioids in cancer response to immunotherapy

Botticelli, A., Cirillo, A., Pomati, G., Cerbelli, B., Scagnoli, S., Roberto, M., Gelibter, A. J., Mammone, G., Calandrella, M. L., Cerbelli, E., et al. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-02784-8 · Cited by 45 · see citing works

Gut microbiota, immunity and pain

Santoni, M., Miccini, F., & Battelli, N. (2020) · Immunology Letters · doi:10.1016/j.imlet.2020.11.010 · Cited by 46 · see citing works

Evidence for Modulation of Substance Use Disorders by the Gut Microbiome: Hidden in Plain Sight

Angoa‐Pérez, M., & Kuhn, D. M. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000144 · Cited by 44 · see citing works

Microbiome and substances of abuse

Salavrakos, M., Leclercq, S., de Timary, P., & Dom, G. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110113 · Cited by 43 · see citing works

Gut dysbiosis associated with the rats' responses in methamphetamine‐induced conditioned place preference

Yang, C., Fu, X., Hao, W., Xiang, X., Liu, T., Yang, B., & Zhang, X. (2020) · Addiction Biology · doi:10.1111/adb.12975 · Cited by 43 · see citing works

A Biopsychosocial Overview of the Opioid Crisis: Considering Nutrition and Gastrointestinal Health

Wiss, D. A. (2019) · Frontiers in Public Health · doi:10.3389/fpubh.2019.00193 · Cited by 41 · see citing works

Technical Aspects of Fecal Microbial Transplantation (FMT)

Bhutiani, N., Schucht, J. E., Miller, K. R., & McClave, S. A. (2018) · Current Gastroenterology Reports · doi:10.1007/s11894-018-0636-7 · Cited by 39 · see citing works

Opioid epidemic and liver disease

Verna, E. C., Schluger, A., & Brown, R. S. (2019) · JHEP Reports · doi:10.1016/j.jhepr.2019.06.006 · Cited by 40 · see citing works

Acetylcholinesterase Inhibitor Pyridostigmine Bromide Attenuates Gut Pathology and Bacterial Dysbiosis in a Murine Model of Ulcerative Colitis

Singh, M., Chand, H. S., Banerjee, S., Agarwal, H. S., Raizada, V., Roy, S., & Sopori, M. L. (2019) · Digestive Diseases and Sciences · doi:10.1007/s10620-019-05838-6 · Cited by 37 · see citing works

Pain and Opioid-Induced Gut Microbial Dysbiosis

Thomas, K. R., Watt, J., Wu, C. M. J., Akinrinoye, A., Amjad, S., Colvin, L., Cowe, R., Duncan, S. H., Russell, W. R., & Forget, P. (2022) · Biomedicines · doi:10.3390/biomedicines10081815 · Cited by 36 · see citing works

Effect of the gut microbiota and their metabolites on postoperative intestinal motility and its underlying mechanisms

Ma, T., Xue, X., Tian, H., Zhou, X., Wang, J.-K., Zhao, Z., Wang, M., Song, J., Feng, R., Li, L., et al. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04215-2 · Cited by 35 · see citing works

The Microbiome and the Gut‐Liver‐Brain Axis for Central Nervous System Clinical Pharmacology: Challenges in Specifying and Integrating In Vitro and In Silico Models

Hawkins, K. G., Casolaro, T. C., Brown, J. A., Edwards, D. A., & Wikswo, J. P. (2020) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1870 · Cited by 34 · see citing works

Opioid Use, Gut Dysbiosis, Inflammation, and the Nervous System

Jalodia, R., Abu, Y. F., Oppenheimer, M. R., Truitt, B., Meng, J., Chupikova, I., Tao, J., Ghosh, N., Dutta, R. K., Kolli, U., et al. (2022) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-021-10046-z · Cited by 35 · see citing works

Morphine Potentiates Dysbiotic Microbial and Metabolic Shifts in Acute SIV Infection

Sindberg, G. M., Callen, S. E., Banerjee, S., Meng, J., Hale, V. L., Hegde, R., Cheney, P. D., Villinger, F. J., Roy, S., & Buch, S. J. (2018) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-018-9805-6 · Cited by 34 · see citing works

Methionine Restriction Improves Gut Barrier Function by Reshaping Diurnal Rhythms of Inflammation-Related Microbes in Aged Mice

Ren, B., Wang, L., Mulati, A., Liu, Y., Liu, Z., & Liu, X. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.746592 · Cited by 33 · see citing works

Ginsenoside Rg1 mitigates morphine dependence via regulation of gut microbiota, tryptophan metabolism, and serotonergic system function

Chen, Z., Lin, Y., Zhou, Q., Shilin, X., Li, C., Lin, R., Li, J., Chen, Y., Luo, C., & Mo, Z. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112935 · Cited by 33 · see citing works

Polypharmacy With High Drug Burden Index (DBI) Alters the Gut Microbiome Overriding Aging Effects and Is Reversible With Deprescribing

Gemikonakli, G., Mach, J., Zhang, F., Bullock, M., Tran, T., El-Omar, E. M., & Hilmer, S. N. (2022) · The Journals of Gerontology Series A · doi:10.1093/gerona/glac195 · Cited by 37 · see citing works

Concomitant use of analgesics and immune checkpoint inhibitors in non-small cell lung cancer: A pharmacodynamics perspective

Prasetya, R. A., Metselaar-Albers, M., & Engels, F. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174284 · Cited by 32 · see citing works

The Underestimated and Overlooked Burden of Diarrhea and Constipation in Cancer Patients

Moschen, A. R., Sammy, Y., Marjenberg, Z. R., Heptinstall, A. B., Pooley, N., & Marczewska, A. M. (2022) · Current Oncology Reports · doi:10.1007/s11912-022-01267-3 · Cited by 33 · see citing works

Relationship between bile salts, bacterial translocation, and duodenal mucosal integrity in functional dyspepsia

Beeckmans, D., Farré, R., Riethorst, D., Keita, Å. V., Augustijns, P., Söderholm, J. D., Vanuytsel, T., Vanheel, H., & Tack, J. F. (2020) · Neurogastroenterology & Motility · doi:10.1111/nmo.13788 · Cited by 31 · see citing works

On the Role of Peripheral Sensory and Gut Mu Opioid Receptors: Peripheral Analgesia and Tolerance

Fürst, S., Zádori, Z., Zádor, F., Király, K. P., Balogh, M., László, S. B., Hutka, B., Mohammadzadeh, A., Calabrese, C., Galambos, A. R., et al. (2020) · Molecules · doi:10.3390/molecules25112473 · Cited by 31 · see citing works

The microbiome

Luković, E., Moitra, V. K., & Freedberg, D. E. (2019) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0000000000000734 · Cited by 30 · see citing works

Gut microbiota in surgical and critically ill patients

Ho, K. M., Kalgudi, S., Corbett, J.-M., & Litton, E. (2020) · Anaesthesia and Intensive Care · doi:10.1177/0310057x20903732 · Cited by 32 · see citing works

Clinical Observation of the Effects of Oral Opioid on Inflammatory Cytokines and Gut Microbiota in Patients with Moderate to Severe Cancer Pain: A Retrospective Cohort Study

Wang, H., Luo, J., Chen, X., Hu, H., Li, S., Zhang, Y., & Chen, S. (2022) · Pain and Therapy · doi:10.1007/s40122-022-00386-w · Cited by 30 · see citing works

Unravelled facets of milk derived opioid peptides: a focus on gut physiology, fractures and obesity

Aslam, H., Ruusunen, A. A., Berk, M., Loughman, A., Rivera, L. R., Pasco, J. A., & Jacka, F. N. (2019) · International Journal of Food Sciences and Nutrition · doi:10.1080/09637486.2019.1614540 · Cited by 30 · see citing works

Effects of Different Cow-Milk Beta-Caseins on the Gut–Brain Axis: A Narrative Review of Preclinical, Animal, and Human Studies

Robinson, S. R., Greenway, F. L., Deth, R. C., & Fayet‐Moore, F. (2024) · Nutrition Reviews · doi:10.1093/nutrit/nuae099 · Cited by 28 · see citing works

Opioid Use Potentiates the Virulence of Hospital Acquired Infection, Increases Systemic Bacterial Dissemination and Exacerbates Gut Dysbiosis in a Murine Model of Citrobacter Rodentium Infection

Wang, F., Meng, J., Zhang, L., & Roy, S. (2018) · Gut Microbes · doi:10.1080/19490976.2019.1629237 · Cited by 28 · see citing works

Contributions of neuroimmune and gut-brain signaling to vulnerability of developing substance use disorders

Lucerne, K. E., Osman, A., Meckel, K. R., & Kiraly, D. D. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108598 · Cited by 26 · see citing works

Prenatal opioid administration induces shared alterations to the maternal and offspring gut microbiome: A preliminary analysis

Grecco, G. G., Gao, Y., Gao, H., Liu, Y., & Atwood, B. K. (2021) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2021.108914 · Cited by 28 · see citing works

Brief Hydromorphone Exposure During Pregnancy Sufficient to Induce Maternal and Neonatal Microbial Dysbiosis

Abu, Y. F., Tao, J., Dutta, R. K., Yan, Y., Vitari, N., Kolli, U., & Roy, S. (2021) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-021-10019-2 · Cited by 28 · see citing works

The Microbiome–Gut–Brain Axis, a Potential Therapeutic Target for Substance-Related Disorders

Fu, X., Chen, T., Cai, J., Liu, B., Zeng, Y., & Zhang, X. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.738401 · Cited by 28 · see citing works

Sensitivity to Morphine Reward Associates With Gut Dysbiosis in Rats With Morphine-Induced Conditioned Place Preference

Zhang, J., Yang, J., Yang, C., Chen, T., Wang, Z., Li, J., Qin, F., Deng, Q., & Zhang, X. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00631 · Cited by 27 · see citing works

Bi-Directionality of the Microbiota-Gut-Brain Axis in Patients With Functional Dyspepsia: Relevance of Psychotherapy and Probiotics

Rupp, S. K., & Stengel, A. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.844564 · Cited by 28 · see citing works

Dose- and Sex-Dependent Bidirectional Relationship between Intravenous Fentanyl Self-Administration and Gut Microbiota

Ren, M., & Lotfipour, S. (2022) · Microorganisms · doi:10.3390/microorganisms10061127 · Cited by 27 · see citing works

Gut microbiota and its role in stress-induced hyperalgesia: Gender-specific responses linked to different changes in serum metabolites

Xu, X., Zhan, G., Chen, R., Wang, D., Guan, S., & Xu, H. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106129 · Cited by 26 · see citing works

Effect of Concomitant Use of Analgesics on Prognosis in Patients Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis

Mao, Z., Jia, X., Jiang, P., Wang, Q., Zhang, Y., Li, Y.-L., Fu, X., Jiao, M., Jiang, L., Liu, Z., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.861723 · Cited by 26 · see citing works

Impact of concomitant medications on the efficacy of immune checkpoint inhibitors: an umbrella review

Li, H., Zhang, L., Yang, F., Zhao, R., Li, X., & Li, H. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1218386 · Cited by 26 · see citing works

Salidroside Alleviates Furan-Induced Impaired Gut Barrier and Inflammation via Gut Microbiota–SCFA–TLR4 Signaling

Wang, Z., Li, L., Li, W., Yan, H., & Yuan, Y. (2024) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.4c02433 · Cited by 25 · see citing works

Opioid‐induced microbial dysbiosis disrupts irinotecan (CPT‐11) metabolism and increases gastrointestinal toxicity in a murine model

Meng, J., Abu, Y. F., Zhang, Y., Zhou, Y., Xie, Y., Yan, Y., Tao, J., Ramakrishnan, S., Chen, C., & Roy, S. (2022) · British Journal of Pharmacology · doi:10.1111/bph.16020 · Cited by 24 · see citing works

Substance use, microbiome and psychiatric disorders

Chivero, E. T., Sil, S., Kumar, M., & Buch, S. J. (2022) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2022.173432 · Cited by 24 · see citing works

Opioids and the Gastrointestinal Tract: The Role of Peripherally Active µ-Opioid Receptor Antagonists in Modulating Intestinal Permeability

Lacy, B. E., & Cangemi, D. J. (2024) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000002887 · Cited by 24 · see citing works

Interactions of the microbiome with pharmacological and non-pharmacological approaches for the management of ageing-related musculoskeletal diseases

Papageorgiou, M., & Biver, E. (2021) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x211009018 · Cited by 22 · see citing works

Targeting the gut microbiome in the management of sepsis-associated encephalopathy

Barlow, B., Ponnaluri, S., Barlow, A., & Roth, W. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.999035 · Cited by 24 · see citing works

Tissue injury and leukocyte changes in post-acute sequelae of SARS-CoV-2: review of 2833 post-acute patient outcomes per immune dysregulation and microbial translocation in long COVID

Islam, M. S., Wang, Z., Abdel‐Mohsen, M., Chen, X., & Montaner, L. J. (2023) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiac001 · Cited by 22 · see citing works

The role of the microbiota in surgical recovery

Krezalek, M. A., & Alverdy, J. C. (2016) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000299 · Cited by 23 · see citing works

Immune Checkpoint Inhibitors and Opioids in Patients with Solid Tumours: Is Their Association Safe? A Systematic Literature Review

Cani, M., Bironzo, P., Garetto, F., Buffoni, L., & Cotogni, P. (2022) · Healthcare · doi:10.3390/healthcare11010116 · Cited by 22 · see citing works

The role of morphine‐ and fentanyl‐induced impairment of intestinal epithelial antibacterial activity in dysbiosis and its impact on the microbiota‐gut‐brain axis

Muchhala, K. H., Kallurkar, P. S., Kang, M., Köşeli, E., Poklis, J. L., Xu, Q., Dewey, W. L., Fettweis, J. M., Jimenez, N. R., & Akbarali, H. I. (2024) · The FASEB Journal · doi:10.1096/fj.202301590rr · Cited by 22 · see citing works

Role of pregnane X-receptor in regulating bacterial translocation in chronic liver diseases

Mohandas, S., & Vairappan, B. (2017) · World Journal of Hepatology · doi:10.4254/wjh.v9.i32.1210 · Cited by 21 · see citing works

Cigarette Smoking and Opium Use in Relation to the Oral Microbiota in Iran

Wu, Z., Han, Y., Caporaso, J. G., Bokulich, N. A., Mohamadkhani, A., Moayyedkazemi, A., Hua, X., Kamangar, F., Wan, Y., Suman, S., et al. (2021) · Microbiology Spectrum · doi:10.1128/spectrum.00138-21 · Cited by 21 · see citing works

Clinical and Preclinical Evidence for Gut Microbiome Mechanisms in Substance Use Disorders

Hofford, R. S., & Kiraly, D. D. (2023) · Biological Psychiatry · doi:10.1016/j.biopsych.2023.08.004 · Cited by 19 · see citing works

Morphine induces changes in the gut microbiome and metabolome in a morphine dependence model

Wang, F., Meng, J., Zhang, L., Johnson, T., Chen, C., & Roy, S. (2018) · Scientific Reports · doi:10.1038/s41598-018-21915-8 · Cited by 238 · see citing works

Morphine-induced dysbiosis and metabolic remodeling of the gut microbiota is transmissible via fecal microbiota transplantation in mice

Zhu, Y., Wan, J., Sawadogo, R. W., Zhong, J.-M., Yao, H., Zhang, Q.-H., Wang, C.-Z., Xu, M., & Yuan, C.-S. (2026) · American journal of clinical and experimental immunology. · doi:10.62347/kplf6948

The role of morphine‐ and fentanyl‐induced impairment of intestinal epithelial antibacterial activity in dysbiosis and its impact on the microbiota‐gut‐brain axis

Muchhala, K. H., Kallurkar, P. S., Kang, M., Köşeli, E., Poklis, J. L., Xu, Q., Dewey, W. L., Fettweis, J. M., Jimenez, N. R., & Akbarali, H. I. (2024) · The FASEB Journal · doi:10.1096/fj.202301590rr · Cited by 22 · see citing works

Morphine tolerance is attenuated in germfree mice and reversed by probiotics, implicating the role of gut microbiome

Zhang, L., Meng, J., Ban, Y. J., Jalodia, R., Chupikova, I., Fernández, I., Brito, N., Sharma, U., Abreu, M. T., Ramakrishnan, S., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1901182116 · Cited by 160 · see citing works

Opioid Use Potentiates the Virulence of Hospital Acquired Infection, Increases Systemic Bacterial Dissemination and Exacerbates Gut Dysbiosis in a Murine Model of Citrobacter Rodentium Infection

Wang, F., Meng, J., Zhang, L., & Roy, S. (2018) · Gut Microbes · doi:10.1080/19490976.2019.1629237 · Cited by 28 · see citing works